Zobrazeno 1 - 10
of 14
pro vyhledávání: '"KAZUKI HASHIMOTO"'
Autor:
Rina Jiromaru, Ryuji Yasumatsu, Kazuki Hashimoto, Yui Nozaki, Yoshinao Oda, Takahiro Hongo, Takafumi Nakano, Hidetaka Yamamoto, Takashi Nakagawa
Publikováno v:
Histopathology. 79:358-369
AIMS p16 is a sensitive surrogate marker for transcriptionally active high-risk human papillomavirus (HR-HPV) infection in oropharyngeal squamous cell carcinoma (OPSCC), but it is not sufficient in all clinical settings. METHODS AND RESULTS We examin
Autor:
Rina Jiromaru, Yui Nozaki, Takahiro Hongo, Takafumi Nakano, Azusa Sugii, Masanobu Sato, Minako Fujiwara, Hidetaka Yamamoto, Kenichi Taguchi, Kazuki Hashimoto, Yoshinao Oda
Publikováno v:
Human Pathology. 109:37-44
Salivary secretory carcinoma (SASC) is frequently associated with ETV6-neurotrophic tyrosine receptor kinase (NTRK) 3 fusion and more rarely with RET, MET, or ALK rearrangement. We aimed to elucidate the potential diagnostic utility of pan-tropomyosi
Autor:
Takahiro Hongo, Hidetaka Yamamoto, Mika Tanabe, Ryuji Yasumatsu, Ryosuke Kuga, Yoshiko Miyazaki, Rina Jiromaru, Kazuki Hashimoto, Yuki Tateishi, Koh-Hei Sonoda, Takashi Nakagawa, Yoshinao Oda
Publikováno v:
The American journal of surgical pathology. 46(7)
High-risk human papillomavirus (HPV) infection in conjunctival and lacrimal sac squamous cell carcinomas (SCCs) has been sporadically reported; however, its prevalence, clinicopathologic significance and surrogate markers have not been fully elucidat
Autor:
Rina Jiromaru, Takahiro Hongo, Takashi Nakagawa, Yui Nozaki, Kazuki Hashimoto, Muneyuki Masuda, Yoshinao Oda, Kenichi Taguchi, Hidetaka Yamamoto, Ryuji Yasumatsu
Publikováno v:
American Journal of Surgical Pathology. 44:305-315
The prevalence and prognostic value of human papillomavirus (HPV) infection and epidermal growth factor receptor (EGFR) alteration in sinonasal squamous cell carcinoma (SNSCC) are not known. The reliability of p16 overexpression as a surrogate for HP
Autor:
Mioko Matsuo, Rina Jiromaru, Muneyuki Masuda, Takashi Nakagawa, Hidetaka Yamamoto, Ryuji Yasumatsu, Kenichi Taguchi, Kazuki Hashimoto, Satoshi Toh, Yui Nozaki, Takahiro Wakasaki, Akihiro Tamae, Ryosuke Kuga, Yoshinao Oda, Takahiro Hongo
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 34(11)
The antitumor efficacies of immune checkpoint inhibitors (ICIs) and the usefulness of potential predictive markers such as programmed death-ligand 1 (PD-L1) expression, density of tumor-infiltrating lymphocytes (TILs) and microsatellite instability (
Autor:
Ryutaro Uchi, Takashi Nakagawa, Tomomi Manako, Takahiro Hongo, Takahiro Wakasaki, Hidetaka Yamamoto, Kuniaki Sato, Mioko Matsuo, Kazuki Hashimoto, Rina Jiromaru, Ryuji Yasumatsu
Publikováno v:
Anticancer research. 41(1)
Background The genetic basis of sinonasal inverted papilloma (SNIP)-derived squamous cell carcinoma (SCC) has not yet been well characterized. Aim To characterize the genetic abnormalities of SNIP and SNIP-derived SCC and to uncover their differences
Autor:
Satoshi Fujii, Toru Ugumori, Naohito Hato, Kazuki Hashimoto, Ryuichi Hayashi, Takashi Mukaigawa
Publikováno v:
Journal of Surgical Oncology. 114:36-43
Background and Objectives The immune checkpoint ligand programmed death ligand-1 (PD-L1) is expressed in various carcinomas and allows carcinoma cells to elude the immune system. PD-L1 expression is associated with the response to anti-programmed dea
Autor:
Yuichiro Higaki, Kenichi Nishiyama, Takafumi Nakano, Torahiko Nakashima, Yoshinao Oda, Kazuki Hashimoto, Hideki Shiratsuchi, Hidetaka Yamamoto, Shizuo Komune, Sadafumi Tamiya
Publikováno v:
Histopathology. 63:378-392
Aims In this study, we aimed to investigate the molecular mechanisms underlying the development of mucoepidermoid carcinoma (MEC). Methods and results In 31 cases, we examined the MAML2 fusion status using reverse transcriptase–polymerase chain rea
Autor:
Sadafumi Tamiya, Yuichiro Higaki, Yoshinao Oda, Kazuki Hashimoto, Hidetaka Yamamoto, Shizuo Komune, Torahiko Nakashima, Kenichi Nishiyama, Masazumi Tsuneyoshi, Hideki Shiratsuchi
Publikováno v:
Histopathology. 60:E131-E142
Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Nishiyama K, Higaki Y, Komune S, Tsuneyoshi M & Oda Y (2012) Histopathology 60, E131–E142 neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and progn
Autor:
Takashi, Mukaigawa, Ryuichi, Hayashi, Kazuki, Hashimoto, Toru, Ugumori, Naohito, Hato, Satoshi, Fujii
Publikováno v:
Journal of surgical oncology. 114(1)
The immune checkpoint ligand programmed death ligand-1 (PD-L1) is expressed in various carcinomas and allows carcinoma cells to elude the immune system. PD-L1 expression is associated with the response to anti-programmed death 1 (PD-1)/PD-L1 drugs. T